Originator Organization Ervaxx Ltd.Startup |
Active Organization- |
Inactive Organization Ervaxx Ltd.Startup |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | GB | Ervaxx Ltd.Startup | 08 May 2022 |